Estadisticas : R-COMP versus R-CHOP as first-line therapy for diffuse large B-cell lymphoma in patients =60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group

Sancho, J.M.
Visitas:952

569 ( Estados Unidos de América )

141 ( Singapur )

65 ( Reino Unido )

65 ( España )

37 ( Alemania )

14 ( Francia )

14 ( Hong kong )

10 ( Finlandia )

7 ( Letonia )

5 ( Suecia )

3 ( Togo )

3 ( Italia )

3 ( India )

3 ( Austria )

2 ( Países Bajos )

2 ( Irlanda )

2 ( México )

1 ( Brasil )

1 ( Rusia )

1 ( Sri lanka )

1 ( Bolivia )

1 ( China )

1 ( Chile )

1 ( Argentina )

Descargas: 751